Back to Agenda
Future-Proofing Your Medical Affairs Organization
Session Chair(s)
Kevin Appareti
Senior Director, Global Medical Science Liaison
Royal Philips, United States
Robin Winter-Sperry, MD
Field Medical Excellence, Global Oncology / International Lead
Pfizer, United States
Healthcare continues to transform at a rapid pace across the globe. In many ways it is a perfect storm of change. There are profound trends that are driving change from global resource constraints to aging populations and the rise of chronic illnesses, to increasing consumer engagement, to broad technology disruption and innovation. The strategic imperative for healthcare providers and industry alike, is to navigate the ecosystem effectively and with purpose to drive better patient outcomes while maintaining a viable economic foundation. Healthcare industry organizations whether it be pharmaceutical, medical device, diagnostics, or others, will survive and indeed “win” when they not only understand the dynamic ecosystem but use their science and technology acumen to drive innovations in partnership with key customers to inform the solutions that ultimately get delivered to patients. Medical Affairs teams are in the perfect position to lead this change and be an integral part of the strategic infrastructure of a company bringing medical/scientific data-driven value to the company’s success.
Learning Objective :
At the conclusion of this session, participants should be able to:
- Identify the major trends and drivers in Healthcare affecting Medical Affairs Organizations
- Translate the implications of these trends to Medical Affairs Organizations
- Apply a strategic planning process to support the value of Medical Affairs Organizations
Speaker(s)
Speaker
Kate Chavez, MBA
McKinsey & Company, United States
Associate Partner
Speaker
Sameer Lal, MBA
Indegene, United States
Senior Vice President, Business Development
Have an account?